Medical schools across the United States are confronting heightened scrutiny and legal pressure amid federal investigations into their admissions practices, particularly those aimed at promoting diversity. Under the Trump administration, investigations spearheaded by the Justice and Education departments have targeted several prominent medical schools, accusing them of discriminating against White and Asian applicants in favor of Black and Hispanic candidates. This legal uncertainty has forced many institutions to reconsider admissions policies traditionally viewed as integral to their mission.
In recent months, the Treasury Department and Internal Revenue Service proposed measures that could strip private schools of their tax-exempt status if they factor race into admissions or related policies, escalating the stakes for medical institutions. Advocates for diversity in medical education emphasize that a heterogeneous healthcare workforce is essential to meeting the needs of a diverse patient population. They note that students from underserved backgrounds are more inclined to serve similarly underserved communities upon graduation.
Michelle Ko, a professor at the University of California at Davis specializing in diversity in medical education, said schools aim to select future physicians who will address critical healthcare shortages in communities nationwide. “We want to choose the students who are going to provide the services we need as a community, as a state, as a country,” she said.
The administration challenges such policies, arguing they prioritize diversity over merit and thus undermine fairness in admissions, particularly in an arena as consequential as medical school selection. Ian Kingsbury, senior director at the Center for Accountability in Medicine, a project opposed to identity-based initiatives in medicine, said the data suggest that discrimination against White and Asian applicants persists within medical school admissions processes. He applauded the government’s efforts to enforce compliance with civil rights laws and cast doubt on claims that patient outcomes improve when doctors share the same racial background as their patients.
Since President Donald Trump’s return to office last year, the Justice Department has initiated numerous investigations into top medical schools, including UCLA, Yale, the University of California campuses at Davis and San Diego, and George Washington University. Several institutions have denied wrongdoing, emphasizing their commitment to lawful, holistic admissions practices designed to identify candidates likely to serve critical healthcare needs. George Washington University, for example, disputed the allegations outright. Yale’s leadership has stressed cooperation with investigations while asserting its right to independently set admissions criteria consistent with the law.
The government contends that even ostensibly race-neutral criteria—such as considering socioeconomic status or life hardships—are often proxies for racial preferences, a position that has not gone unchallenged. The Biden administration, in contrast, has supported the use of such race-neutral methods to promote diversity and address inequities in healthcare education.
The ongoing efforts have also drawn attention from lawmakers. In July, the House Committee on Education and the Workforce held a contentious hearing with medical school representatives, where members debated the role of race and other factors in admissions decisions. Some Republicans accused schools of lowering standards for students of color, while Democrats highlighted the importance of considering applicants’ commitment to serving underserved areas.
The conflict extends beyond investigations to civil litigation. In May 2025, advocacy groups filed suit against UCLA’s medical school, alleging racial discrimination in admissions. The Justice Department joined the suit in January, requesting the termination of federal funding and repayment of grant money provided since 2023. The complaint cited enrollment data showing a decline in the proportion of White and Asian students admitted compared to their application rates.
Edward Blum, an advocate behind the lawsuit known for challenging affirmative action policies, said the evidence indicates that UCLA sought to balance its class racially, which he says violates the Supreme Court’s 2023 ruling that struck down race-conscious admissions.
Yet, legal experts acknowledge the issue remains unresolved. The Supreme Court ruling prohibits direct consideration of race but allows for race-neutral strategies that still achieve diverse student bodies. The Association of American Medical Colleges (AAMC) has advised its members that such approaches align with legal precedent and are vital to improving healthcare workforce diversity. David J. Skorton, AAMC's chief executive, emphasized the importance of diversity in medical education, noting that patient outcomes depend on it.
Despite attempts by the Trump administration to broadly restrict diversity efforts, including a 2025 Education Department directive declaring many such policies illegal, courts have pushed back against these expansive interpretations. One federal court struck down the guidance, noting the department attempted to alter schools’ legal obligations without appropriate procedures. Although the administration later withdrew the directive, it signaled continued intent to enforce its interpretation of the law.
Frank Trinity, chief legal officer at AAMC, characterized the legal landscape as unsettled and expressed concern that schools might accept restrictive agreements with the government that exceed what courts might ultimately impose.
As medical schools navigate this evolving environment, they face mounting pressure from multiple directions: the federal government demanding adherence to civil rights laws as it interprets them, lawmakers debating admissions standards, faculty and students urging the preservation of diversity initiatives, and courts weighing the boundaries of legal admissions practices. The outcome of this dispute will likely shape the admissions landscape and the diversity of the health care workforce for years to come.